Many patients undergoing carotid endarterectomy (CEA) regularly take clopidogrel, a permanent platelet inhibitor. The authors sought to determine whether taking clopidogrel in the period before CEA leads to more bleeding or other complications.
The authors performed a retrospective, institutional review board–approved review of 182 consecutive patients who underwent CEA. Clinical, radiographic, and surgical data were gleaned from hospital and clinic records. Analysis was based on the presence or absence of clopidogrel in patients undergoing CEA and was performed twice by considering clopidogrel use within 8 days and within 5 days of surgery to define the groups.
Taking clopidogrel within 8 days before surgery resulted in no statistical increase in any measure of morbidity or death. Taking clopidogrel within 5 days was associated with a small but significant increase in operative blood loss and conservatively managed postoperative neck swelling. No measure of permanent morbidity or death was increased in either clopidogrel group.
Findings in this study support the safety of preoperative clopidogrel in patients undergoing CEA.
Abbreviations used in this paper: APA = antiplatelet agent; CEA = carotid endarterectomy.
BurgerWChemnitiusJMKneisslGDRückerG: Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med257:399–4142005
de BorstGJHilgevoordAAde VriesJPvan der MeeMMollFLvan de PavoordtHD: Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring. Eur J Vasc Endovasc Surg34:135–1422007
KapetanakisEIMedlamDAPetroKRHaileEHillPCDullumMK: Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?. Circulation113:1667–16742006
MarkusHSDrosteDWKapsMLarrueVLeesKRSieblerM: Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation111:2233–22402005
PayneDAJonesCIHayesPDNaylorARGoodallAH: Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight. Stroke38:2464–24692007
PayneDAJonesCIHayesPDThompsonMMLondonNJBellPR: Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation109:1476–14812004
PfistererMBrunner-La RoccaHPBuserPTRickenbacherPHunzikerPMuellerC: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus baremetal stents. J Am Coll Cardiol48:2584–25912006
SpertusJAKettelkampRVanceCDeckerCJonesPGRumsfeldJS: Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation113:2803–28092006